Drug Development

Nov 04, 2016
By Pharmaceutical Technology Editors
Researchers in the University of Dundee have discovered a new method of activating drugs to combat visceral leishmaniasis. The discovery could lead to better treatments for neglected tropical diseases.
Nov 02, 2016
Pharmaceutical Technology
Recent astronomical price increases have driven accusations that some pharma companies are price-gouging.
Nov 02, 2016
Pharmaceutical Technology
Outcry against high pharmaceutical pricing brings questions of high R&D costs and restrictive payers, but also drug development and manufacturing efficiency.
Nov 02, 2016
Pharmaceutical Technology
This article will clarify reasonable expectations for the responsibilities of topical product formulation developers and for excipient suppliers regarding the information and samples for experiments needed for QbD.
Oct 27, 2016
By Pharmaceutical Technology Editors
The collaboration follows the signing of a cooperative research agreement between Sanofi Pasteur, Fiocruz, and WRAIR.
Oct 27, 2016
By Pharmaceutical Technology Editors
Teva and IBM expanded their partnership to focus on drug development and chronic disease management.
Oct 21, 2016
By Pharmaceutical Technology Editors
Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.
Oct 18, 2016
By Pharmaceutical Technology Editors
The agency awarded 21 new clinical trial research grants to boost the development of treatments for rare diseases.
Oct 10, 2016
By Pharmaceutical Technology Editors
The agency’s Patient-Focused Drug Development program completed its commitment ahead of schedule.
Oct 05, 2016
By Pharmaceutical Technology Editors
Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck KGaA’s Parteck SRP 80 sustained-release excipient is well suited for direct compression.
native1_300x100
lorem ipsum